Colonoscopy Bowel Prep Comparison Among Diabetic Patients

Exclusion Criteria

• •1. Unable to provide informed consent to participate in the study Such as a mental condition rendering the participant unable to understand the nature, scope, and possible consequences of the study
• •2. Clinically relevant cardiovascular, hepatic, neurological, endocrine, or other major systemic disease making implementation of the protocol or interpretation of the study results difficult or that would put the participant at risk by participating in the study
• •3. Persistent significant or severe infection, either acute or chronic
• •4. Prior use of any investigational drug in the preceding 6 months
• •5. Liver function impairment or persisting elevations (confirmed by retest) of alanine aminotransferase (ALT), aspartate aminotransferase (AST), or direct bilirubin greater than 2x the upper limit of normal range (ULN).
• •6. Pregnant or breast-feeding women or those who plan to become pregnant during the study
• •7. Participants with significantly impaired bone marrow function or significant anemia, leukopenia, or thrombocytopenia (confirmed by retest):
• •1. Hematocrit \< 35% and/or
• •2. Absolute white blood cell count \< 3000 cells/mm3 ( L) and/or
• •3. Platelet count \< 150 000 cells/mm3 ( L) and/or- Absolute neutrophil = 1500 cells/mm3 ( L)
• •8. History of colorectal cancer
• •9. Inflammatory Bowel Disease
• •10. Past surgical history of colon resection
• •11. Prior history of colorectal surgery
• •12. Family history of hereditary polyposis and cancer disorders to include but not limited to FAP (Familial Adenomatous Polyposis), Gardner Syndrome, Turcot Syndrome, Lynch Syndrome, Cowden Syndrome, and Peutz-Jeghers Syndrome
• •13. Symptomatic patients (bleeding, diarrhea, constipation, abdominal pain)